A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Fujirebio Diagnostics

Status: Terminated

Conditions: Small Cell Lung Cancer

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT01591512

FDI-36

Details and patient eligibility

About

The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.

Enrollment: 4 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18
• Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
• Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy.
• Able to understand and willing to provide Informed Consent

Exclusion criteria

• No diagnosis of SCLC
• Not scheduled to undergo treatment for the diagnosis of SCLC
• Unable to provide Informed Consent